Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
0.781
+0.010 (1.31%)
At close: Dec 20, 2024, 4:00 PM
0.795
+0.014 (1.79%)
After-hours: Dec 20, 2024, 5:30 PM EST
Lucid Diagnostics Employees
Lucid Diagnostics had 70 employees as of December 31, 2023. The number of employees decreased by 4 or -5.41% compared to the previous year.
Employees
70
Change (1Y)
-4
Growth (1Y)
-5.41%
Revenue / Employee
$59,843
Profits / Employee
-$747,343
Market Cap
43.30M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 70 | -4 | -5.41% |
| Dec 31, 2022 | 74 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Rapid Micro Biosystems | 193 |
| Omega Therapeutics | 94 |
| CollPlant Biotechnologies | 75 |
| Xilio Therapeutics | 73 |
| Gain Therapeutics | 32 |
| enVVeno Medical | 31 |
| Cardio Diagnostics Holdings | 9 |
LUCD News
- 2 days ago - Lucid Diagnostics Partners with VITALExam to Enhance Esophageal Precancer Detection for Firefighters - PRNewsWire
- 10 days ago - Prospective Clinical Utility Study of Lucid Diagnostics' EsoGuard® Esophageal DNA Test Accepted for Peer-Reviewed Publication - PRNewsWire
- 18 days ago - Lucid Diagnostics Completes Convertible Debt Refinancing to Strengthen Balance Sheet and Extend Cash Runway Past Key Near-Term Milestones - PRNewsWire
- 4 weeks ago - Lucid Diagnostics Submits Clinical Evidence Package to MolDX Seeking Medicare Coverage for EsoGuard® Esophageal DNA Test - PRNewsWire
- 4 weeks ago - Lucid Diagnostics to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum - PRNewsWire
- 5 weeks ago - Lucid Diagnostics Inc. (LUCD) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Lucid Diagnostics Provides Business Update and Third Quarter 2024 Financial Results - PRNewsWire
- 6 weeks ago - Lucid Diagnostics' ESOGUARD BE-1 Prospective Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing Accepted for Peer-Reviewed Publication - PRNewsWire